Haleon plc (NYSE:HLN – Get Free Report) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 25,670,000 shares, a growth of 40.0% from the January 15th total of 18,340,000 shares. Currently, 0.6% of the shares of the stock are short sold. Based on an average daily volume of 8,640,000 shares, the days-to-cover ratio is presently 3.0 days.
Analysts Set New Price Targets
Several brokerages have weighed in on HLN. Morgan Stanley lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Three analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $10.95.
Check Out Our Latest Report on HLN
Institutional Investors Weigh In On Haleon
Haleon Trading Down 2.5 %
Shares of HLN traded down $0.25 on Friday, hitting $9.71. 5,836,820 shares of the stock traded hands, compared to its average volume of 12,350,782. The firm has a market capitalization of $43.93 billion, a P/E ratio of 28.54, a P/E/G ratio of 2.70 and a beta of 0.28. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon has a 1 year low of $7.89 and a 1 year high of $10.80. The stock’s 50 day moving average is $9.54 and its two-hundred day moving average is $9.80.
Haleon Company Profile
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Featured Stories
- Five stocks we like better than Haleon
- How to Invest in the FAANG Stocks
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- Using the MarketBeat Dividend Yield Calculator
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Golden Cross Stocks: Pattern, Examples and Charts
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.